TherapeuticsMD (TXMD) Other financing activities (2010 - 2023)

TherapeuticsMD (TXMD) has reported Other financing activities for 13 consecutive years, with -$1.1 million the latest figure, recorded in Q3 2023.

• For the quarter ending Q3 2023, Other financing activities fell 251.85% year-over-year to -$1.1 million; the trailing twelve-month figure through Mar 2024 stood at -$1.1 million (down 124.98% YoY), and the FY2022 full-year result was $3.3 million, down 35.09% from the prior year.
• Other financing activities retreated to -$1.1 million in Q3 2023 per TXMD's latest filing, from $1000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $6.6 million in Q2 2019 and bottomed at -$1.1 million in Q3 2023.
• Historically, Other financing activities has averaged $1.5 million across 5 years, with a median of $729000.0 in 2022.
• The sharpest annual moves came in 2020 and 2023: Other financing activities jumped 1148.66% in 2020, then sank 251.85% in 2023.
• Over 5 years, Other financing activities stood at -$270.0 in 2019, then soared by 463062.96% to $1.2 million in 2020, then slumped by 90.56% to $118000.0 in 2021, then soared by 2097.46% to $2.6 million in 2022, then plunged by 142.69% to -$1.1 million in 2023.
• According to Business Quant data, Other financing activities over the past three periods registered -$1.1 million, $1000.0, and $1.1 million for Q3 2023, Q2 2023, and Q1 2023 respectively.